2015
DOI: 10.15407/fz61.04.048
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Peptide Semax on Synaptic Activity and Short-Term Plasticity of Glutamatergic Synapses of Co-Cultured Dorsal Root Ganglion and Dorsal Horn Neurons

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2016
2016
2019
2019

Publication Types

Select...
2
1
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 11 publications
0
4
0
Order By: Relevance
“…the pain threshold is lowered, indicating that it is a successful model. For neuropathic pain, both cell electrophysiology and immunohistochemistry showed significantly increased P2X2 receptor expression, indicating that the neuropathic pain is closely related to the P2X2 receptor expression 24–26 .…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…the pain threshold is lowered, indicating that it is a successful model. For neuropathic pain, both cell electrophysiology and immunohistochemistry showed significantly increased P2X2 receptor expression, indicating that the neuropathic pain is closely related to the P2X2 receptor expression 24–26 .…”
Section: Discussionmentioning
confidence: 98%
“…P2X2/3 subtypes use primary sensory neurons while transmitting the nociception and algesia information 22,23 . The selective P2X2/3 and P2X3 receptor antagonists, in experimental pain models, effectively reduce neuropathic pain 24–26 . The CCI rats behave analogously with the neuropathic pain conditions of human beings, which were therefore used as the neuropathic pain model 27 .…”
Section: Introductionmentioning
confidence: 99%
“…Therapeutic Semax peptide with primary sequence Met-Glu-His-Phe-Pro-Gly-Pro [34] was selected in present chapter as the first peptide for study. Semax is one of the few synthetic regulatory peptides that, after all the fundamental research, have found its application in therapy as a nootropic and neuroprotective agent [35].…”
Section: Semax Peptidementioning
confidence: 99%
“…Due to this ability to make complexes the dendrigrafts like other dendritic molecules could be used as multifunctional nanocarriers for delivery of drug or/and other molecules [9] for treatment of various disease. Therapeutic Semax peptide [10] was selected for our study as a model peptide because it belongs to a class of regulatory peptides and has an antioxidant, antihypoxic and neuroprotective properties. Semax peptide is used for acute ischemic stroke prevention, during traumatic brain injury treatment, recovery of a patient after a stroke, in the case of optic nerve disease and glaucoma optic neuropathy.…”
Section: Introductionmentioning
confidence: 99%